Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinglong Liu

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Mbio|February 10, 2021
Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc<b>γ</b> Receptor-Dependent and -Independent PathwaysLei Yu, Xinglong Liu, Xianmiao Ye, et al.
Emerging Microbes & Infections|May 4, 2021
Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patientsQihong Yan, Ping He, Xiaohan Huang, et al.
Frontiers in Immunology|July 26, 2021
Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 PatientChangchun Lai, Xinglong Liu, Qihong Yan, et al.
Emerging Microbes & Infections|May 28, 2019
Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse modelXuefeng Niu, Lingzhai Zhao, Linbing Qu, et al.
Nature Communications|August 23, 2020
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaquesLiqiang Feng, Qian Wang, Chao Shan, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Mbio|February 10, 2021
Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc<b>γ</b> Receptor-Dependent and -Independent PathwaysLei Yu, Xinglong Liu, Xianmiao Ye, et al.
Emerging Microbes & Infections|May 4, 2021
Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patientsQihong Yan, Ping He, Xiaohan Huang, et al.
Frontiers in Immunology|July 26, 2021
Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 PatientChangchun Lai, Xinglong Liu, Qihong Yan, et al.
Emerging Microbes & Infections|May 28, 2019
Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse modelXuefeng Niu, Lingzhai Zhao, Linbing Qu, et al.
Nature Communications|August 23, 2020
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaquesLiqiang Feng, Qian Wang, Chao Shan, et al.
Pageof 14